C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
11/2006
11/08/2006	EP1718616A2 Isoquinoline derivatives
11/08/2006	EP1718615A1 Novel quinoline-carbaxamides as jack3 kinase modulators
11/08/2006	EP1718611A1 3-3-di-substituted-oxindoles as inhibitors of translation initiation
11/08/2006	EP1718609A1 Substituted azetidine compounds, their preparation and use as medicaments
11/08/2006	EP1718608A1 Viral polymerase inhibitors
11/08/2006	EP1718305A1 Pyrimidine derivatives and use thereof as agricultural and horticultural fungicides
11/08/2006	EP1718297A2 Novel chemical compounds
11/08/2006	EP1303514B9 Process for preparing azacycloalkanoylaminothiazoles
11/08/2006	EP1294691B1 Serine protease inhibitors
11/08/2006	EP1021190B1 Amid derivatives as growth hormone release promotors
11/08/2006	CN1860117A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
11/08/2006	CN1860116A Bicyclic compounds and compostions as pdf inhibitors
11/08/2006	CN1860113A Nicotinamide derivatives useful as PDE4 inhibitors
11/08/2006	CN1860107A Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof
11/08/2006	CN1283638C Indole-2-formamide compounds as factor Xa inhibitors
11/08/2006	CN1283630C 3-substituted piperazine triadimenol antifungal compounds and their salts
11/08/2006	CN1283626C Substituted benzene derivatives or salts thereof
11/08/2006	CN1283252C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage
11/07/2006	USRE39384 Substituted thiazolidinedione derivatives
11/07/2006	US7132542 Compounds for the treatment of male erectile dysfunction
11/07/2006	US7132443 Fluoropyrrolidines as dipeptidyl peptidase inhibitors
11/07/2006	US7132439 Bis-benzimidazoles and related compounds as potassium channel modulators
11/07/2006	US7132436 Inhibitors of 11-β-hydroxy steroid dehydrogenase type 1
11/07/2006	US7132427 Quinazolines and uses thereof
11/07/2006	US7132425 5-substituted-six-membered heteroaromatic glucokinase activators
11/07/2006	US7132423 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme
11/07/2006	US7132420 Aspartic protease inhibitors
11/07/2006	US7132418 For therapy and prophylaxis of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis, psoriasis
11/07/2006	US7132416 Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia
11/07/2006	CA2261802C Use of xanomeline for treating bipolar disorder
11/07/2006	CA2192824C Pyridone-carboxylic acid derivatives, processes for the preparation thereof and anti-tumor agents containing the pyridone-carboxylic acid derivatives
11/07/2006	CA2146961C Heterobicyclic sulfonamide and sulfonic ester derivatives
11/07/2006	CA2132132C Process for the preparation of 3-arylbenzofuranones
11/02/2006	WO2006116713A1 Substituted amide derivatives as protein kinase inhibitors
11/02/2006	WO2006116355A1 Ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
11/02/2006	WO2006114706A1 Triazole derivatives as vasopressin antagonists
11/02/2006	WO2006114606A1 Fused thiazole derivatives as kinase inhibitors
11/02/2006	WO2006114371A1 Novel compounds for treating inflammatory diseases
11/02/2006	WO2006114333A1 New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
11/02/2006	WO2006114313A1 Pyrazole compounds as prostaglandin receptors ligands
11/02/2006	WO2006114274A1 Oxazole and thiazole compounds and their use in the treatment of pge2 mediated disorders
11/02/2006	WO2006091428A3 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006088921A3 Pyrazinyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006088919A3 Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity
11/02/2006	WO2006088837A3 Heterocyclic substituted piperazines with cxcr3 antagonist activity
11/02/2006	WO2005103034A8 Novel piperidine substituted diaminothiazoles
11/02/2006	US20060247435 Novel intermediates for linezolid and related compounds
11/02/2006	US20060247283 5-(3,3-Dichloroprop-2-enyloxy)-2-[4-(2,2-dimethylbenzo[d]1,3-dioxolan-4-yloxy)butoxy]-1,3-dichlorobenzene; acaricides
11/02/2006	US20060247279 polymorphic form rosiglitazone maleate, used for prophylaxis of diabetes in humans; crystal structure
11/02/2006	US20060247262 2,4 Di (hetero) -arylamino-pyrimidine derivatives as ZAP-70 and/or syk inhibitors
11/02/2006	US20060247259 Urea derivatives containing aromatic or heteroaromatic rings; 4-(3-chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide; prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective
11/02/2006	US20060247253 Novel heterocyclic NF-kB inhibitors
11/02/2006	US20060247243 Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors
11/02/2006	US20060247242 Pesticidal compositions
11/02/2006	US20060247233 Thiazoles inhibitors of the alk-5 receptor
11/02/2006	US20060247232 Heterocyclic compound and antitumor agent containing the same as effective ingredient
11/02/2006	US20060247230 chemokines receptor modulators such as 4-(2-ethyl-6-fluoro-3-{1-[3-(4-fluoro-phenylsulfanyl)-propyl]-piperidin-4-yl}-indol-1-yl)-benzoic acid ethyl ester, used for treating inflammatory diseases such as asthma and allergic diseases, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis
11/02/2006	US20060247229 Sulfonyl substituted n-(biarylmethyl) aminocyclopropanecarboxamides
11/02/2006	US20060247212 Heterocyclic compounds having inhibitory activity against HIV integrase
11/02/2006	US20060247210 such as (4-Benzothiazol-2-yl-1H-pyrazol-3-yl)-[2-(1H-imidazol-4-yl)-ethyl]-amine, used in the treatment of disorders associated with hyperproliferation and tissue remodelling or repair, inflammation, cell migration and invasion, and renal diseases, or as protein kinase inhibitors
11/02/2006	US20060247178 Mitotic kinesin inhibitors and methods of use thereof
11/02/2006	EP1717231A1 Substituted azole compounds and thereof preparation and application
11/02/2006	EP1717229A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
11/02/2006	EP1717226A1 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension
11/02/2006	EP1717225A1 Bicyclic amide derivatives
11/02/2006	EP1717220A2 Vanilloid receptor ligands and their use in treatments
11/02/2006	EP1716144A2 Processes for making pioglitazone and compounds of the processes
11/02/2006	EP1716128A1 Substituted 4,5,6,7-tetrahydro-benzothiazol-2-ylamine compounds
11/02/2006	EP1716127A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
11/02/2006	EP1716122A1 Modulators of atp-binding cassette transporters
11/02/2006	EP1715867A1 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
11/02/2006	EP1636219B1 Novel thiazolylmethyl pyrazoles, method for the production thereof, and use thereof in dyes for keratin fibers
11/02/2006	EP1578723A4 Process for the preparation of oxazolidinones and method of use thereof
11/02/2006	EP1539747B1 N-aroyl cyclic amines as orexin receptor antagonists
11/02/2006	EP1446394B1 Novel 1,2,4-thiadiazole derivatives as melanocortin receptor modulators
11/02/2006	EP1406620B1 Vinyl phenyl derivatives as glk activators
11/02/2006	EP1399117B1 Dyeing composition for keratinous fibres comprising a particular dicationic diazo dye
11/02/2006	EP1202976B1 Pyrazinones, compositions containing such compounds
11/02/2006	EP1192133B1 N-cyclopentyl modulators of chemokine receptor activity
11/02/2006	EP1003721B1 Benzylidene-1,3-dihydro-indol-2-one derivatives as receptor tyrosine kinase inhibitors, particularly of raf kinases
11/02/2006	EP0821683B1 Benzimidazole compounds and their use as modulators of the gaba a receptor complex
11/02/2006	CA2607426A1 Fused thiazole derivatives as kinase inhibitors
11/02/2006	CA2605756A1 New thiazolidinones without basic nitrogen, their production and use as pharmaceutical agents
11/02/2006	CA2605603A1 Ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disorders
11/01/2006	CN1856490A Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators
11/01/2006	CN1856489A Phenyl-carboxamide compounds useful for treating pain
11/01/2006	CN1856479A Gamma-secretase inhibitors
11/01/2006	CN1856477A 异喹啉钾通道抑制剂 Isoquinoline potassium channel inhibitors
11/01/2006	CN1856473A Isoquinolinone potassium channel inhibitors
11/01/2006	CN1856310A 喹唑啉钾通道抑制剂 Quinazoline potassium channel inhibitors
11/01/2006	CN1856308A Excitatory amino acid receptor antagonists
11/01/2006	CN1856249A Pyridyl pyrimidines for use as pesticides
11/01/2006	CN1854135A Heteronuclear compound with dicyandiamide connection and its medicinal use
11/01/2006	CN1854118A Indane acetic acid compound
11/01/2006	CN1853630A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
10/2006
10/31/2006	US7129359 for treating infection by enterovirus of the Picornaviridae family ; exemplified by: 1-[2-(4'-Chloro-biphenyl-4-yloxymethyl)-benzyl]-3-pyridin-4-yl-imidazolidin-2-one
10/31/2006	US7129261 Cytotoxic agents
10/31/2006	US7129260 Isoindolinone kinase inhibitors
10/31/2006	US7129258 Substituted benzoxazoles as estrogenic agents
10/31/2006	US7129254 highly active active agents from the structural class of the epothilones and epothilone derivatives with suitable linkers; to link these epothilone-linker conjugates to recognition units, such as, for example, monoclonal antibodies or fragments thereof, to form immune conjugates

1 ... 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 ... 628